Abstract
Potent and selective small molecules targeting specific proteins are essential tools for investigating biological processes and for the development of new therapeutics. Despite their importance, current small molecules only target approximately 10% of the human proteome. This limited coverage persists because the development of new chemical inhibitors remains time-consuming, expensive, an…
